Lv3
390 积分 2024-10-29 加入
One Mutation to Rule Them All: Mutant KRAS Controls Tumor Intrinsic and Microenvironment Signaling
2个月前
已完结
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
2个月前
已完结
Abstract 5264: KRASG12C inhibition synergizes with checkpoint blockade in KRASG12C-mutated tumor model
5个月前
已关闭
LBA1: First-line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study
5个月前
已完结
Efficacy and safety of KRAS -G12C inhibitors in colorectal cancer: a systematic review of clinical trials
5个月前
已完结
TargetingKRAS G12Cmutations in colorectal cancer
5个月前
已完结
Efficacy and safety of KRAS -G12C inhibitors in colorectal cancer: a systematic review of clinical trials
5个月前
已完结
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer
5个月前
已关闭
Genome-wide identification of abnormal alternative splicing and RBP regulators in intestinal failure-associated liver disease
5个月前
已完结
皖公网安备34019202002308
